University College, London: Parkinson Disease trials
The registry lists 17 Parkinson Disease studies with University College, London as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 7Phase 3 4No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform TrialRecruitingNCT07207057Phase 3
- Ambroxol to Slow Progression in Parkinson DiseaseRecruitingNCT05778617Phase 3
- Parkinson's Families ProjectRecruitingNCT02760108
- Brain Sensing in Neurological and Psychiatric DisordersStatus unknownNCT04810325
- Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's DiseaseCompletedNCT04232969Phase 3
- Trial of Ondansetron as a Parkinson's HAllucinations TreatmentActive, not recruitingNCT04167813Phase 2
- Antidepressants Trial in Parkinson's DiseaseCompletedNCT03652870Phase 3
- Imaging Neuromelanin and Iron in Dystonia/ParkinsonismStatus unknownNCT03572114
- A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") DysfunctionCompletedNCT03421899
- Short Pulse Width DBS in Parkinson's DiseaseCompletedNCT03417271Phase 2
- Ambroxol in Disease Modification in Parkinson DiseaseCompletedNCT02941822Phase 2
- The CloudUPDRS Smartphone Software in Parkinson's Study.Status unknownNCT02937324Not applicable
- Melatonin for Nocturia in Parkinson's DiseaseStatus unknownNCT02359448Phase 2
- Care for Late Stage ParkinsonismCompletedNCT02333175Not applicable
- Trial of Exenatide for Parkinson's DiseaseCompletedNCT01971242Phase 2
- Nucleus Basalis Deep Brain Stimulation for Thinking & Memory Problems in Parkinson's.CompletedNCT01701544Phase 1/2
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot StudyStatus unknownNCT01174810Phase 2